Transcriptomics

Dataset Information

0

Inhibition of the autocrine loop IL6-JAK2-STAT3-Calprotectin as targeted therapy for HR-/HER2+ breast cancers

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE62251 | GEO | 2015/09/03

SECONDARY ACCESSION(S): PRJNA263583

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Inhibition of the autocrine loop IL6-JAK2-STAT3-Calprotectin as targeted therapy for HR-/HER2+ breast cancers
2015-09-03 | E-GEOD-62251 | biostudies-arrayexpress
Unknown Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers.
| S-EPMC4536311 | biostudies-literature
Genomics,Multiomics Inhibition of the autocrine loop IL6-JAK2-STAT3-Calprotectin as targeted therapy for HR-/HER2+ breast cancers
| PRJNA263583 | ENA
Unknown JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.
| S-EPMC5840758 | biostudies-other
Unknown The SRSF1/circATP5B/miR-185-5p/HOXB5 feedback loop regulates the proliferation of glioma stem cells via the IL6-mediated JAK2/STAT3 signaling pathway.
| S-EPMC8051130 | biostudies-literature
Unknown AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.
| S-EPMC4254172 | biostudies-literature
Unknown Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
| S-EPMC4741886 | biostudies-other
Unknown JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
| S-EPMC4136898 | biostudies-literature
Unknown Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma <i>via</i> IL6-JAK2/STAT3 Signaling Pathway Under Hypoxia.
| S-EPMC7985451 | biostudies-literature
Unknown HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis.
| S-EPMC3129398 | biostudies-literature